MR编号 | DE/H/0640/002 |
---|
药品名称 | Ondansetron Kabi 0,08 mg/ml Infusionslösung |
---|
活性成分 | - ondansetron hydrochloride 0.08 mg/ml
|
---|
剂型 | Solution for infusion |
---|
上市许可持有人 | Fresenius Kabi Deutschland GmbH
Else-Kroener-Strasse 1
61352 Bad Homburg
Germany |
---|
参考成员国 - 产品名称 | Germany (DE) Ondansetron Kabi 0,08 mg/ml Infusionslösung |
---|
互认成员国 - 产品名称 | - Ireland (IE)
- Portugal (PT)
- Spain (ES)
- Bulgaria (BG)
Ondansentron Kabi - Italy (IT)
- Cyprus (CY)
Ondansetron/Kabi 0,08 mg/ml διάλυμα για έγχυση - Greece (GR)
- Croatia (HR)
- Sweden (SE)
- Estonia (EE)
- Norway (NO)
- Finland (FI)
- Lithuania (LT)
Ondansetron Kabi 0,08 mg/ml infuzinis tirpalas - Luxembourg (LU)
- Poland (PL)
Ondansetron Kabi - Romania (RO)
Ondansetron Kabi 0,08 mg/ml soluție perfuzabilă - Hungary (HU)
- Slovenia (SI)
- Denmark (DK)
- Austria (AT)
- Czechia (CZ)
Ondansetron Kabi - Belgium (BE)
- Slovakia (SK)
- Iceland (IS)
- Netherlands (NL)
- United Kingdom (Northern Ireland) (XI)
- Latvia (LV)
|
---|
许可日期 | 2022/03/03 |
---|
最近更新日期 | 2024/06/13 |
---|
药物ATC编码 | |
---|
申请类型 | - TypeLevel1:Known Active Substance
- TypeLevel2:Initial Application
- TypeLevel3:Other Generic application Art 10.3 Dir 2001/83/EC
- TypeLevel4:Chemical Substance
- TypeLevel5:Prescription Only
|
---|
附件文件下载 | |
---|
市场状态 | Positive |
---|